臺大醫院;臺大醫院-內科部;臺大醫學院-一般醫學科;Chen C.-Y.Chuang S.-Y.Fang C.-C.Huang L.-C.Hsieh I.-C.Pan W.-H.Yeh H.-I.CHAU-CHUNG WUYin W.-H.Chen J.-W.2014-02-142018-07-112014-02-142018-07-112013http://ntur.lib.ntu.edu.tw//handle/246246/259325Background: The aim of this study was to clarify the current status in the effective control of dyslipidemia in Taiwanese women and men with coronary heart disease (CHD). Materials and methods: A total 1584 patients with CHD (1188 men, aged 64.8 +/- 11.6 years and 396 women, aged 69.0 +/- 9.8 years) from 3486 patients who had atherosclerotic vascular disease and complete lipids measured values [total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C)] were used for analysis. Results: The waist, height, weight, and creatinine levels were higher in men than in women. The systolic blood pressure, TC, HDL-C, LDL-C, fasting blood glucose, and platelet were lower in men than in women. Men were more likely to achieve the target goal than women in TC < 160 mg/dL, LDL-C < 100 mg/dL, and TG < 150 mg/dL as well as to achieve HDL-C goal. Conclusion: A significant gap was found between the guidelines and clinical practice in statin intervention among these CHD patients, particularly for women. The strategy in control of dyslipidemia should consider gender difference. Copyright (c) 2013, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.108 bytestext/htmldyslipidemialow-density lipoprotein cholesterol (LDL-C)statin[SDGs]SDG3acipimox; atorvastatin; colestyramine; creatinine; ezetimibe; fibric acid derivative; fluindostatin; glucose; high density lipoprotein; high density lipoprotein cholesterol; hydroxymethylglutaryl coenzyme A reductase inhibitor; lipid; low density lipoprotein cholesterol; nicotinic acid; pravastatin; rosuvastatin; simvastatin; triacylglycerol; adult; aged; article; atherosclerotic cardiovascular disease; body height; body weight; cholesterol blood level; controlled study; drug efficacy; dyslipidemia; female; glucose blood level; human; ischemic heart disease; lipid blood level; major clinical study; male; priority journal; sex difference; systolic blood pressure; thrombocyte; treatment outcome; waist circumference10.1016/j.ijge.2013.03.002http://ntur.lib.ntu.edu.tw/bitstream/246246/259325/1/index.html